Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD34+ Selected Donor Cell Boost for Management of Poor Graft Function or Primary or Secondary Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation

NCT06569082 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT06569082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06569082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD34+ Selected Donor Cell Boost for Management of Poor Graft Function or Primary or Secondary Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2024
Completion date
August 31, 2035
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft failure, poor graft function